Castle Biosciences shareholders approve officer exculpation charter amendment; re-elect directors

CASTLE BIOSCIENCES INC

Stockholders approved amendment to certificate of incorporation to limit officer liability per Delaware law, effective May 22, 2025.
Re-elected Class III directors Kimberlee S. Caple, G. Bradley Cole, and Derek J. Maetzold to terms expiring 2028.
Ratified KPMG as independent auditor for FY2025 with 23.7M votes for, 20.8K against.
Approved advisory say-on-pay proposal with 20.0M for, 1.3M against, 43K abstain.
All proposals passed with overwhelming support; broker non-votes noted for director election and say-on-pay.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

CASTLE BIOSCIENCES INC: Amended and restated certificate of incorporation to add Article IX providing for exculpation of officers as permitted by Delaware law (effective 2025-05-22).

Change: charter amendment
Effective: 2025-05-22

Exact text from the filing

On May 22, 2025, the Company filed the A&R Charter with the Secretary of State of the State of Delaware, which became effective upon filing.

View on SEC.gov

Browse all governance changes →

CASTLE BIOSCIENCES INC filing history →

Source: SEC EDGAR

accession 0001447362-25-000085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.